Zydus Cadila's Coronavirus vaccine Virafin gets emergency use approval

Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of "Virafin", Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults. India has been struggling since more than a month after the second wave of Coronavirus hit the country. Take a look at the report.